Growing awareness towards potential causes of hair loss is driving the growth in global alopecia treatments market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Alopecia Treatments Market By Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis), By Gender (Male, Female), By Route of Administration (Topical, Oral, Injectable), By End User (Hospitals, Dermatologic and Trichology Clinics, Home Care Settings, Aesthetic Clinics), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2026”, the global alopecia treatments market is projected to grow at an impressive CAGR in the forecast period, 2022-2026, owing to rising instances of chronic diseases globally coupled with rapidly growing geriatric population of the world. Moreover, the geriatric population is more susceptible to alopecia since, achieving the age, consumers have deteriorating health conditions in major cases. Healthy nutrients are not that readily absorbed by the body and thus lack of nutrients causes the consumers to lose hair, teeth, and have deteriorating skin condition, etc. Moreover, rise in the prevalence of diseases like cancer is also one of the major reasons behind the growth of the market. During the radiation therapies, in case of severe phases of cancer, the patient often looses the hair and achieves baldness. These patients can be children, young adults, adults, or geriatric patients. Availability of the artificial wigs and fake hair hats, along with the increased acceptance among the population for the balding may create some restraints over the global alopecia treatments market in the next five years.
Alopecia treatment is a plan carried out for the issues of hair loss. The condition is seen among both male and female patients that belong to any age, be it young adult, adults, or the geriatric population. There are five kinds of alopecia namely, androgenic alopecia, alopecia areata, ciatricial alopecia, traction lopecia, alopecia totalis. Androgenic alopecia is the most prevailing kind of alopecia in the whole world. It affects men more than the female population. Alopecia areata is an autoimmune disease that attacks the hair follicles and ultimately causes complete baldness to the patient. Hormonal changes, hereditary conditions, radiation therapies for cancer treatment, stress, etc. are some of the major causes of hair loss among the wide age groups of the patients.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “ Global Alopecia Treatments Market”
https://www.techsciresearch.com/report/alopecia-treatment-market/7466.html
The global alopecia treatment market is segmented by disease type, gender, route of administration, end user, distribution channel, competitional landscape, and regional distribution. Based on gender, the market is divided between male and female consumers. Female consumers are anticipated to hold the larger share of the market over male consumers. Major reason among the females for the loss of hair is postmenopausal syndromes. Although the changing trend and social acceptability has somewhat enhanced, but loss of hair among the women is still questionable and socially not acceptable as much as baldness and lack of hair among the men. Moreover, androgenetic alopecia is higher among the women and it can severely affect the women’s emotional and psychological imbalances. The fear of not being accepted, made fun of, and social awkwardness renders a woman with the low quality of life.
Based on route of administration, the market is further segmented into topical, oral, and injectable. Topical drugs or topical treatment is the application of the therapeutic on the skin or the epidermal tissues of the skin. The product range includes, lotions, oils, creams, or hair masks, etc. Oral therapeutics are pills, tablets, capsules, tonics, etc,. that are supposed to be administered through mouth (eating/drinking). These drugs are often taken coupled with the other kind of route of administrations.
Major companies operating in the market are Aclaris Therapeutics Inc., Concert Pharmaceuticals Inc., Daiichi Sankyo Inc., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Histogen Inc, Pfizer Inc., Eli Lilly and Company Ltd., Bioniz Therapeutics Inc., Reistone Biopharma Company Limited, among others. Market players are focused on the advanced therapeutic availability along with the technologically advanced methods of the treatment applications. Other strategies considered are positive and prolonged partnerships for consistent distribution and supply of the related products.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7466
Customers can also request for 10% free customization on this report.
“With-holding half of the global market shares, North America is anticipated to be the most promising market region in the next five years. The region is expected to assert its dominance over the market shares on the account of adoption of efficient and technologically sound products related to alopecia treatments. Moreover, the region has some of the largest economies like United States and Canada, that support the presence of market giants like Johnson & Johnson Inc., etc. Presence of the major market players supports the research and development of the technologically advanced products and thereby supporting the growth of the market in the region. Asia Pacific is also anticipated to hold the significant shares and fastest CAGR due to improving healthcare infrastructure, advancing healthcare structures like hospitals and clinics equipped with advanced medical facilities,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Alopecia Treatments Market By Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis), By Gender (Male, Female), By Route of Administration (Topical, Oral, Injectable), By End User (Hospitals, Dermatologic and Trichology Clinics, Home Care Settings, Aesthetic Clinics), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global alopecia treatments market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global alopecia treatments market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]